D-1063-2016 Class III Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-1063-2016 was initiated by Dr. Reddy's Laboratories, Inc. on Jun 3, 2016 and is designated Class III. Reason for recall: Failed impurities/degradation: out of specification result for impurity secorapamycin. The recall status is terminated (terminated Apr 7, 2017). Affected quantity: 9,330 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 13, 2016
Initiation Date
Jun 3, 2016
Termination Date
Apr 7, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,330 bottles

Product description

Sirolimus Tablets, 1 mg, 100-count bottle, Rx only, Manufactured by: Dr. Reddy's Laboratories Limited, Visakhapatnam - 5300046 India, NDC 55111-653-01

Reason for recall

Failed impurities/degradation: out of specification result for impurity secorapamycin.

Distribution pattern

Nationwide

Code information

Lot # H400044, H400045 , Exp 07/16; H400048, Exp 08/16; H400055, Exp 10/16; H400070, H400071, H400073 and H400074, Exp 11/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1063-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1063-2016. Report a data issue: hello@regdatalab.com.